Conservative treatment concept for stable angina pectoris in coronary heart disease;Konservative Behandlungskonzepte fur die stabile Angina pectoris bei koronarer Herzkrankheit

Medizinische Klinik

Volumn 91, Issue 7, 1996, Pages 458-465

  Schoebel, Frank Chris ^a   Leschke, Matthias ^a   Heintzen, Matthias Paul ^a   Strauer, Bodo Eckehard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BISOPROLOL; CALCIUM ANTAGONIST; CARNITINE; COLESTYRAMINE; DILTIAZEM; METOPROLOL; MEVINOLIN; NIFEDIPINE; NITRIC ACID DERIVATIVE; PRAVASTATIN; PROBUCOL; TRIMETAZIDINE; UROKINASE; VERAPAMIL; CALCIUM CHANNEL BLOCKING AGENT;

ANGINA PECTORIS; BLOOD RHEOLOGY; DIET; DRUG CHOICE; DRUG EFFICACY; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; REVIEW; CORONARY ARTERY BLOOD FLOW; CORONARY DISEASE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; PHYSIOLOGY; TREATMENT OUTCOME;

ANGINA;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; CORONARY DISEASE; ELECTROCARDIOGRAPHY; HUMANS; NITRATES; TREATMENT OUTCOME;

EID: 0029665581     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Akhras, F., G. Jackson: Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina. Lancet 338 (1991), 1036-1039.
2. Anderson, T. J., J. T. Meredith, A. C. Yeung, B. Frei, A. P. Selwyn, P. Ganz: The effect of cholesterol-lowering and antioxidant therapy on indothelium-dependent coronary vasomotion. N Engl. J. Med. 332 (1995), 488-493
3. Benson, H , D. P. Mc Callie Jr: Angina pectoris and the placebo effect. New Engl. J. Med 300 (1979), 1424-1429.
4. Beta-blacker heart attack trial research group. A randomised trial of propranolol in patients with acute myocardial infarction: 1. mortality results JAMA 247 (1982), 1707-1714.
5. Boddeke, E., J. Hugentburg, W. Jap, J. Heynis, P. van Zwieten: New anti-ischemic drugs: cytoprotecove with no primary haemodynamic effects. Trends in Pharmacol. Sci. 10 (1989), 397-400
6. Boden, W. E., E. W. Bough, M. J. Reichman, V B. Rich, P. M. Young, K. S. Korr, R. S. Shulman: Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates. a randomized, double-blind, placebo-controlled cross-over study. Circulation 71 (1985), 1197-1205.
7. Braunwald, E., R. H. Jones, D. B. Mark, J. Brown, L. Brown, M. D. Cheitlin, C. A. Concannon, M. Cowan, C. Edwards, V. Fuster, L Goldman, L. A. Green, C. Green, C. Grines, B. W. Lytle, K. M. McCauley, A. I. Mushlin, G. C. Rose, E. E Smith, J. A. Swain, E. J. Topol, J. T. Willerson: Diagnosing and managing unstable angina. Circulation 90 (1994), 613-622.
8. Broderick, T.L., A. Quinney, C Barker, G. D. Lopa-schuk: Beneficial effect of carnitine on mechnical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 87 (1993), 972-981
9. Brown, G. B., X. Q. Zhao. D. E. Sacco, J. J. Albers: Lipidlowering and plaque regression - New insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation 87 (1993), 178-1791.
10. Cacciatore, L., R. Cerio, M. Ciarimboli, M. Cocozza, V Goto, L. D'Alessandro, G. Grattarola, L. Imparato, M. Lingetti, M. Mancini, U. Oliviero, D. Policicchio, F. A. Porfido, F. Rengo, G. P. Sorrentino: The therapeutic effect of L-carnitine in patients with exercise-induced stable angina: a controlled study. Drugs Exptl. Clin. Res. 17 (1991), 225-235.
11. Campeau, L.: Grading of angina pectoris. Circulation 54 (1976),522-523.
12. Casino, P. R , C. M. Kilcoyne, A A. Quyyumi, J. M. Hoeg, J. A. Panza: The role of nitric oxide in endothe'lium-dependet yasodilation of hypercholesterolemic patients. Circulation 88 (1993),2541-2547.
13. Catrouk, P., N. Benchekroun, J. Robert, J. Cambar: Influence of trimetazidine on deleterious, effects of oxygen radical species. in post-ischemic acute renal failure in the rat. Cardiovasc. Drugs Ther. 4 (1990), 816-817.
14. Cherchi, A., C. Lai, E. Onnis, E. Orani, R. Pirisi, M. R. Pisano, A Soro, M. Corsi: Propionyl. carnitine in stable effort angina Cardiovasc Drugs Ther 4 (1990), 481 .
15. Cohn, P.F., P. Harris, W. H. Barry, R. A. Rosati, P. Rosenbaum, C. Waternaux: Prognostic importance of anginal symptoms in angiographically defined coronary artery disease. Amer. J. Cardiol. 47 (1981), 233-237.
16. Cohn, P.F.; Total ischemic burden: pathophysiology and prognosis. Amer. J. Cardiol. 59 (1987), 3C-6C.
17. Creager, M.A., J. P. Cooke, M. E. Mendelsohn, S. J. Gallagher, S. M. Coleman, J. Loscalzo, V. J. Dzau: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. clin. Invest. 86 (1990), 228-234.
18. Davini, P., A Bigalli, F. Lamanna, A. Boem: Controlled study on L-camitine therapeutic efficacy in postinfarction. Drugs Exptl. clin. Res. 18 (1992), 355-365.
19. Dalla-Volta, S., G. Maraglino, P. Della-Valentina, P. Vienna, A. Desideri: Comparison of trimetazidine with nifidipine in effort angina: a double blind cross-over study. Cardiovasc Drugs Ther 4 (1990), 853-860.
20. Droste, C., H. Roskamm: Silent myocardial ischmia. Amer. Heart J. 118 (1989), 1087-1092.
21. Egashira, K., Y. Hirooka, H. Kai, M. Sugimachi, S. Suzuki, T. Inou, A Takeshita: Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 89 (1994), 2519-2524.
22. Ferrari, R., C. Ceconi, A. Cargnoni, E. Pasini, G. M. Buffa, S. Curello, O. Visoli: The effect of proprionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria. Cardiovasc Drugs Ther. 5 (1991), 57-66.
23. Fuster, V., L Badimon, J. Badimon, J. Chesebro: The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts). New Engl. J. Med. 326 (1992), 242-250.
24. Gibson, R S., P. M. Young, W. E. Boden, K Schechtmann, R. Roberts: Prognostic significance and beneficial effect of diltiazem on the incidence of ealry receurent ischemia after non Q-wave myocardia infarction: Results from the multicenter diltiazem study. Amer. J. Cardiol. 60 (1987), 203-209.
25. Gould, K L., J. P. Martucci, D. I. Goldberg, M. J. Hess, R. P. Edens, R. Latifi, S. J. Dudnck: Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 89 (1994), 1530-1538.
26. Guamieri, C., C. Muscari: Effect of trimetazidine on mitochondrial funtion and oxidative damage during reperfusion of ischemic hypertrophied rat myocardium. Pharmacology 46 (1993), 324-331.
27. Hugentburg, J. G., T. J. W. Jap, M. J. Mathy, P. N. M. van Heinigen, V. A. Bohnenn, J. B. Heijnis, H. W. G. M. Boddeke, P. A. Zwieten: Cardioprotective effect of trimetazidine and niefedipine in guinea-pig hearts subjected to ischemia Arch. int. Pharmacodyn. 300 (1989), 186-208
28. Humen, D. P., P. O'Brian, P. Purves, D. Johnson, W. J. Kostuk: Effort angina with adequate beta-receptor blockade: Comparison with diltiazem alone and in combination. J. Amer Coll Cardiol 7 (1986), 329-335.
29. ISIS-1 (First international study of infarct survival) Collaborative study group: Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infaction: ISIS-1. Lancet 2 (1986), 57-66.
30. Kaiser, G. C., K. B Davis, L D. Fisher, W. O. Myerts, E. D. Foster, E. R. Passamani, M. J. Gillespie: Survival following coronary bypass grafting in patients with severe angina pectoris (CASS). J. Thorac. Cardiovasc Surg. 89 (1985), 513-524
31. Katz, R. I., W. S. Weintraub, M. M. Bodenheimer, J. B. Agarwal, V. S. Banka, R. H. Helfant, Failure of low dose nifedipine to improve exercise tolerance in stable angina. Am Coll Cardiol 49 (1982), 895.
32. Kaski, J. C., L. Rodriguez-Plaza, D. O. Meran, L. Araujo, S. Chierchia, A. Maseri: Improved coronary supply: mechanisms of action of nitrates in chronic stable angina. Amer. Heart J 110 (1985), 238-245
33. Kober, G., S Pennaforte, T. Buck, H. Sievert, C. Vallbracht: Myocardial cytoprotection during transluminal coronary angioplasty. Europ. Heart J. 14 (1993), Suppl. G, 6-11.
34. Kurz, T., B Rauch, W. Kübler: Antianginöse Therapie der koronaren Herzerkrankung. Mono- oder Kombinationsbehandlung. Z Kardiol. 80 (1991), 305-316.
35. Leschke, M., H. Hoffken, A. Schmudtsdorff, H. Blanke, R. Egbnng, K. Joseph, B. E. Strauer: Einfluß von Fenofibrat auf Fibnnogenkonzentration und Blutfluidität. Dtsch med Wschr. 114 (1989), 939-944.
36. Leschke. M., H. Höffken, W. Motz, H. Blanke, F. C. Schoebel, B. E. Strauer: Chronisch-intermittierende Urokinasetherapie bei therapierefraktärer Angina pectoris. Dtsch. med. Wschr. 117 (1992), 81-87.
37. Leung, W H., C. P. Lau. C. K. Wong: Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet 341 (1993), 1496-1500.
38. Lichtlen, P. R.: Pathophysiology of coronary and myocardial function in angina pectoris: important aspects for drug treatment. Europ, Heart J. 6 (1985), Suppl. F, 11-25.
39. Lubsen, J., J. G. Tijessen: Efficacy of nifedipine and metroprolol in the early treatment of unstable angina in the coronary care unit: Findings from the Holland Interuniversity nifedipine/metroprolot trial (HINT). Amer. J. Cardiol. 60 (1987), 18A-25A.
40. Maseri, A., S. Chierchia, J. C. Kaski: Mixed angina pectoris. Amer. J. Cardiol. 56 (1985), 30E-33E.
41. Maseri A.: Medical therapy of chronic stable angina pectoris. Circulation 82 (1990), 2258-2262.
42. Maseri, A., S. Chierchia, G. Davies, J. Glazier: Mechanisms of ischemic cardiac pain and silent myocardial ischmia. Amer. J. Cardiol 70 (1985), Suppl. 3A, 7-11.
43. Morse, J. R.: Comparison of combination nifedipinpropranolol and diltiazem-propranolol with high dose diltrazem monotherapy for stable angina pectoris. Amer. J. Cardiol. 62 (1988), 1028-1032.
44. Mulcahy, D., J. Keegan, D. Cunningham, A. Quyyumi, P. Crean, A. Park, C. Wright, K. Fox: Circadian variations of total ischemic burden and its alteration with antianginal agents. Lancet 2 (1988),755-758.
45. Nesto, R. W., G. J. Kowalchuk: The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Amer. J. Cardiol. 57 (1987), 23C-30C.
46. Noms, R. M., E. D. Clarke, N. L. Sammel, W. M. Smith, B Williams: Protective effect of propranolol in threatened myocardial infarction. Lancet 2 (1978), 907-909.
47. Norwegian Multicenter Study Group. Timolol-induced reduction on mortality and reinfarction in patients surviving acute myocardial infarction. New Engl. J. Med. 304 (1981), 801-807.
48. Ornish, D., S. E Brown, L. W. Scherwitz, J. H. Billings, W. T. Armstrong, T. A. Ports, S. M. McLanahan, R. L. Kirkeeide, R. J. Brand, K. L Gould: Can lifestyle changes reverse coronary heart disease? - The Lifestyle Heart Trial Lancet 336 (1990), 129-133.
49. Opie, L. H: The mechanism of myocyte death in ischmia. Europ. Heart J. 14 (1993), Suppl. G, 31-33.
50. Packer, M.: Combined beta-adrenergic and calcium entry blockade in angina pectoris, New Engl. J. Med. 320 (1989), 709-718.
51. Sampson, J. J., M. D. Cheitlin: Pathophysiology and differential diagnosis of cardiac pain. Progr. Cardiovasc. Dis. 13 (1971), 507-531.
52. Schoebel, F. C., M. Leschke, D. Stein, M. Heins, K. Pels, T. W. Jax, B. E Strauer: Chronic-intermittent urokinase therapy in refractory angina pectoris. Fibrinolysis 9 (Suppl. 1) (1995), 121-125.
53. Schoebel, F. C., M Leschke, B. E. Strauer: Therapierefraktäre Angina pectons - pathophysiologische Grund-lagen und alternative Therapieansätze. Dtsch. med. Wschr. 121 (1995), 301-307
54. Schuler, G., R Hambrecht, G. Schlierf, J. Niebauer, K. Hauer, J. Neumann, E. Hoberg, A. Drinkmann, F. Bacher, M Grunze, W. Kübler: Regular physical exercise and low-fat diet - Effects on progression of coronary artery disease. Circulation 86 (1992), 1-11.
55. Seiler, C , O. M. Hess, M. Buechi, T. M. Suter, H. P. Krayenbuehl: Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 88 (1993), 2139-2148 (part 1).
56. Shub, C.: Stable angina pectons: 3. Medical treatment. Mayo Clin. Proc. 65 (1990), 256-273.
57. Stone. P. H., J. E. Muller, Z. G. Tun, E. Geltman, A S. Jaffe, E. Braunwald: Efficacy of nifedipine therapy in patients with refractory angina pectoris: Significance of the presence of coronary vasospasm. Amer. Heart J 106 (1983), 644-652.
58. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II). Amer. J. Cardiol. 66 (1990), 779-785.
59. The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. New Engl. J. Med. 319 (1938), 385-392.
60. Tolins, M., E. K. Weir, E. Chesler, G. L. Pierpont: "Maximal" drug therapy is not necessarrily optimal in chronic angina pectoris. J Amer. Coll. Cardiol. 3 (1984), 1051-1057.
61. Treasure, C. B., J. L, Klein, W. S. Weintraub, J. Talley, M. E. Stillablower, A. S. Kosinski, J. Zhang, S. J. Boccuzzi, J. C. Cedarholm, W. Alexander: Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with, coronary artery disease. New Engl. J. Med. 332 (1995), 481-487.
62. White, H. D., J. F. Polak, J. Wynne, B. L. Holman, E. M Antman, R. W. Nesto: Addition of nifedipine to maximal nitrate and beta-adrenoreceptor blocker therapy in coronary artery disease. Amer. J. Cardiol. 55 (1985), 1303-1307.
63. Weiner, D. A., M. D. Klein: Verapamil therapy for stable exertiorial angina pectoris. Amer. J. Cardiol. 50 (1982), 1153-1157.
64. Winsor, T., H. J. Berger. Oral nitroglycerin as a prophylactic antianginal drug: Clinical, physiological and statistical evidence of efficacy on a three-phase experimental design. Amer. Heart J. 90 (1975), 611-626.
65. Winniford, M. D , R. L. Huxley, L. D. Huillis: Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina on effort. Amer. Heart J. 107 (1983), 492-498.
66. Yusuf, S., P. Sleight, P. Rossi, D. Rarnsdale, R. Peto, L. Furze, H. Steery, M. Pearson, R. Motwani, S. Parish, R. Gray, D. Bennett, C. Bray: Reduction in infarcts size, arrhythmias and chest pain by early intravenous beta-blockade in suspected myocardial infarction. Circulation 67 (1983), Suppl. 1, 32-41.
67. Zeiher, A. M., H. Drexler, H. Wollschläger, H. Just: Modulation of coronary vasomotor tone in humans - Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83 (1991), 391-401.
68. Zhukova, L, A. Yurenev, V. Kukharchuk, E. Pomerantsev, V. Titov, B. Shabalink, A. Martinov: Long-term experience with lovastatin treatment in patients with coronary heart disease and hyperlipoproteinemia type II. Europ. Heart J. 13 (Suppl. B), (1992), 7-10.